Skip to main content

ScienceDex / Researcher record

Vakoc, Christopher

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #736
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Long-Funded
  • Diverse Portfolio

NIH Funding · FY2023

$5M
Full award amounts, FY2023
5
Records listing this PI
#736
By linked amount among FY2023 PIs
2013
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2013$549,0471#13,597
2014$532,5761#14,507
2015$557,7621#14,116
2016$557,7621#14,466
2017$557,7621#14,930
2019$1,404,4393#5,254
2020$821,4662#4,084
2021$1,628,8394#4,659
2022$1,376,3503#6,399
2023$4,998,8885#736

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20131 record
  2. FY20141 record
  3. FY20151 record
  4. FY20161 record
  5. FY20171 record
  6. FY20193 records
  7. FY20202 records
  8. FY20214 records
  9. FY20223 records
  10. FY2023 · selected5 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vakoc, Christopher. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award records by amount

NIH award records listing Vakoc, Christopher as a PI. Multi-PI records show the full award amount for context.

  • 2P01CA013106-51P01Contact PI
    Targeting Transcription and Splicing in Cancer
    $2.9M
    award amount
  • 1R01CA281106-01A1R01Contact PI
    Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
    $742.5K
    award amount
  • 5R01CA174793-10R01Contact PI
    BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
    $541.1K
    award amount
  • 5U01CA242919-05U01Contact PI
    Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
    $430.4K
    award amount
  • 5R01CA229699-05R01Contact PI
    Targeting aberrant enhancer landscapes in pancreatic cancer
    $404.8K
    award amount

Award organization

Organizations that administered FY2023 awards listing Vakoc, Christopher as a PI.

FY2023 award administered by Cold Spring Harbor Laboratory (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2013
    First NIH Award
    Cold Spring Harbor Laboratory
  2. 2013
    $500K Cumulative Funding
  3. 2014
    $1M Cumulative Funding
  4. 2016
    $2M Cumulative Funding
  5. 2016
    R01 Grant Holder
  6. 2019
    Entered Top 50% Nationally
    Ranked #5254
  7. 2019
    Program/Center Grant Leader
  8. 2020
    Entered Top 25% Nationally
    Ranked #4084
  9. 2021
    $5M Cumulative Funding
  10. 2023
    $10M Cumulative Funding
  11. 2023
    Entered Top 10% Nationally
    Ranked #736
  12. 2023
    Entered Top 5% Nationally
    Ranked #736